Literature DB >> 6721266

Bacteremic nosocomial pneumonia. Analysis of 172 episodes from a single metropolitan area.

C S Bryan, K L Reynolds.   

Abstract

We studied 172 episodes of bacteremia attributed to nosocomial pneumonia in 168 patients, observed in the 4 major hospitals of a single metropolitan area over a 5-yr period. Overall mortality for these patients was 58%. Deaths attributed directly to nosocomial pneumonia occurred almost exclusively in patients with serious and largely irreversible underlying diseases. These data confirm the high mortality associated with endemic hospital-acquired pneumonia. Although some deaths appear to be preventable, primarily by measures designed to reduce the risk of aspiration, analysis of the data herein raises doubts whether overall mortality can be significantly reduced by currently available measures.

Entities:  

Mesh:

Year:  1984        PMID: 6721266     DOI: 10.1164/arrd.1984.129.5.668

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  41 in total

Review 1.  Diagnosis of pneumonia and monitoring of infection eradication.

Authors:  M Ruiz; C Arosio; P Salman; T T Bauer; A Torres
Journal:  Drugs       Date:  2000-12       Impact factor: 9.546

Review 2.  Nosocomial pneumonia in the intensive care unit: mechanisms and significance.

Authors:  C A'Court; C S Garrard
Journal:  Thorax       Date:  1992-06       Impact factor: 9.139

3.  Initial antimicrobial treatment of hospital acquired pneumonia in adults: A conference report.

Authors:  L A Mandell; T J Marrie; M S Niederman
Journal:  Can J Infect Dis       Date:  1993-11

4.  Outcome in bacteremia associated with nosocomial pneumonia and the impact of pathogen prediction by tracheal surveillance cultures.

Authors:  Pieter Depuydt; Dominique Benoit; Dirk Vogelaers; Geert Claeys; Gerda Verschraegen; Koenraad Vandewoude; Johan Decruyenaere; Stijn Blot
Journal:  Intensive Care Med       Date:  2006-09-16       Impact factor: 17.440

5.  Ventilator-associated pneumonia: diagnosis, treatment, and prevention.

Authors:  Steven M Koenig; Jonathon D Truwit
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

6.  Polyclonal and monoclonal antibody therapy for experimental Pseudomonas aeruginosa pneumonia.

Authors:  J E Pennington; G J Small; M E Lostrom; G B Pier
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

Review 7.  Systemic and endotracheal antibiotic prophylaxis of nosocomial pneumonia in ICU.

Authors:  H Lode; G Höffken; B Kemmerich; T Schaberg
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

Review 8.  Antimicrobial agent therapy for Pseudomonas aeruginosa.

Authors:  J A Korvick; V L Yu
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

9.  Use of pulsed-field gel electrophoresis as an epidemiologic tool during an outbreak of Pseudomonas aeruginosa lung infections in an intensive care unit.

Authors:  D Talon; G Capellier; A Boillot; Y Michel-Briand
Journal:  Intensive Care Med       Date:  1995-12       Impact factor: 17.440

10.  Emerging pathogens in nosocomial pneumonia.

Authors:  S L Berk; A Verghese
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-01       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.